fracture
Showing 9976 - 10000 of >10,000
Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (LY2127399, Placebo)
Completed
- Relapsing-Remitting Multiple Sclerosis
- LY2127399
- Placebo
-
Phoenix, Arizona
- +62 more
Nov 10, 2018
Osteoporosis Trial in Yokkaichi
Unknown status
- Osteoporosis
-
Yokkaichi, Mie, JapanTomidahama Hospital
Oct 18, 2016
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (FF/GW642444 Inhalation Powder, GW642444 Inhalation Powder)
Completed
- Pulmonary Disease, Chronic Obstructive
- FF/GW642444 Inhalation Powder
- GW642444 Inhalation Powder
-
Birmingham, Alabama
- +187 more
Oct 9, 2017
Atherosclerosis Trial in Los Angeles (Oral 17B-estradiol, Placebo)
Completed
- Atherosclerosis
- Oral 17B-estradiol
- Placebo
-
Los Angeles, CaliforniaAtherosclerosis Research Unit, Division of Cardiovascular Medici
Jun 5, 2017
Gingivitis Trial in Las Vegas (Stannous Fluoride, Sodium Monofluorophosphate)
Completed
- Gingivitis
- Stannous Fluoride
- Sodium Monofluorophosphate
-
Las Vegas, NevadaGSK Investigational Site
Sep 25, 2017
NSCLC, Lung Tumors Trial in Worldwide (HKI-272)
Completed
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
-
Los Angeles, California
- +18 more
Apr 6, 2018
Non-Squamous NSCLC Trial in Italy (erlotinib)
Completed
- Non-Squamous Non-Small Cell Lung Cancer
-
Napoli, Campania, Italy
- +9 more
Dec 21, 2017
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CHOP, rituximab [MabThera/Rituxan])
Completed
- Lymphoma, Large B-Cell, Diffuse
- CHOP
- rituximab [MabThera/Rituxan]
-
Blida, Algeria
- +185 more
Sep 11, 2017
Ankle Fracture, Rehabilitation Trial in Korea, Republic of (Early weightbearing, Non-weightbearing)
Unknown status
- Ankle Fracture
- Rehabilitation
- Early weightbearing
- Non-weightbearing
-
Anyang-si, Gyeonggi-do, Korea, Republic of
- +3 more
Oct 8, 2015
Arthritis, Rheumatoid Trial in Worldwide (adalimumab 40 mg, sirukumab 100 mg, sirukumab 50 mg)
Completed
- Arthritis, Rheumatoid
- adalimumab 40 mg
- +3 more
-
Birmingham, Alabama
- +108 more
Sep 25, 2017
CRC (Colorectal Cancer) Trial in Worldwide (Ruxolitinib, Regorafenib, Placebo)
Effects of Endometriosis on Bone Mineral Density
Completed
- Endometriosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
MDD Trial in Worldwide (LY2216684, Placebo, SSRI)
Completed
- Major Depressive Disorder
- LY2216684
- +2 more
-
Garden Grove, California
- +48 more
Mar 26, 2018
Osteoporosis, Postmenopausal Bone Loss Trial in Farmington (Mediterranean Diet)
Completed
- Osteoporosis
- Postmenopausal Bone Loss
- Mediterranean Diet
-
Farmington, ConnecticutUCHC
May 8, 2017
Scleritis Trial run by the NEI (Gevokizumab)
Completed
- Scleritis
- Gevokizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018
Zoledronic Acid in Osteoporosis of Multiple Disabilities
Completed
- Multiple Disability
- Osteoporosis
- Zoledronic Acid
-
Vandoeuvre les nancy, FranceChildren's Hospital - CHRU de Nancy
Sep 28, 2017
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (FF Inhalation Powder, FF/GW642444 Inhalation Powder, GW642444
Completed
- Pulmonary Disease, Chronic Obstructive
- FF Inhalation Powder
- +3 more
-
Birmingham, Alabama
- +148 more
Jan 18, 2018
The Unstable Thoracic Cage Injury
Completed
- Thoracic Spine Fracture
- Concomitant Sternal Fracture
- (no location specified)
Aug 3, 2015
Arthroplasty, Replacement, Hip Trial in United States (Accolade® TMZF® Hip Stem)
Completed
- Arthroplasty, Replacement, Hip
- Accolade® TMZF® Hip Stem
-
Newport Beach, California
- +10 more
Jul 7, 2017
Healthy Volunteer Trial in Cypress, San Antonio (Denosumab CP4, Denosumab CP2)
Completed
- Healthy Volunteer
- Denosumab CP4
- Denosumab CP2
-
Cypress, California
- +1 more
Jul 18, 2017